Orchestra BioMed Holdings, Inc. (OBIO) Net Income by Year
Orchestra BioMed Holdings, Inc. reported a net loss of $52.7M in fiscal year 2025. This represents an increase of 13.6% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $59.0M net loss. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters Orchestra BioMed Holdings, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
OBIO Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
OBIO Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Orchestra BioMed Holdings, Inc. financials
Frequently Asked Questions
What was Orchestra BioMed Holdings, Inc.'s net income in fiscal year 2025?
Orchestra BioMed Holdings, Inc. reported a net loss of $52.7M in fiscal year 2025.
How fast is Orchestra BioMed Holdings, Inc.'s net income growing?
Orchestra BioMed Holdings, Inc. (OBIO) net income rose by 13.6% year over year, from -$61.0M to -$52.7M in fiscal year 2025.
What is Orchestra BioMed Holdings, Inc.'s net income over the last twelve months?
Orchestra BioMed Holdings, Inc. (OBIO) reported a $59.0M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Orchestra BioMed Holdings, Inc.'s net income changed over the years?
Across the 5 fiscal years this page covers, Orchestra BioMed Holdings, Inc. (OBIO) net income went from -$379K in fiscal year 2021 to -$52.7M in fiscal year 2025.
What was Orchestra BioMed Holdings, Inc.'s net income in the most recent quarter?
Orchestra BioMed Holdings, Inc. (OBIO) reported -$23.8M in net income in Q2 2026. This represents a decrease of 22.7% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Orchestra BioMed Holdings, Inc. (OBIO) reported on that line in every period on record.